Dr Reddys Laboratories (RDY) Cash from Operations (2024 - 2025)

Dr Reddys Laboratories (RDY) recorded quarterly Cash from Operations of 178540405.71 in Q3 2025, up 4.45% quarter-over-quarter from 170935643.25 in Q2 2025, and up 60.52% on a YoY basis from 111227522.36 in Q3 2024.

Dr Reddys Laboratories (RDY) Cash from Operations (2024 - 2025) Analysis & Trends

Dr Reddys Laboratories' Cash from Operations history runs 2 years deep, the most recent figure standing at 178540405.71 for Q3 2025.

  • In Q3 2025, Cash from Operations rose 60.52% year-over-year to 178540405.71; the TTM figure through Sep 2025 stood at 562551153.3 (changed N/A YoY), while the FY2026 annual figure was 751000000.0, down 3.59% from the prior year.
  • Cash from Operations was 178540405.71 for Q3 2025 at Dr Reddys Laboratories, up from 170935643.25 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 178540405.71 in Q3 2025 to a low of 101847581.98 in Q2 2024.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn -40.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 401.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 463.30 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 145.80 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 13.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -165.74 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 89.36 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 125.13 Mn
10 Dr Reddys Laboratories 122.03 Mn -51.98 Mn 368.55 Mn -

Historic Data

Download Data
DateValue
Sep 30, 2025 178.54 Mn
Sep 30, 2025 178.54 Mn
Jun 30, 2025 170.94 Mn
Jun 30, 2025 170.94 Mn
Sep 30, 2024 111.23 Mn
Sep 30, 2024 111.23 Mn
Jun 30, 2024 101.85 Mn
Jun 30, 2024 101.85 Mn